期刊文献+

超声检查肱动脉FMD和sCD40L对急性冠状动脉综合征的预测价值 被引量:3

Value of brachial artery FMD and sCD40L in predicting acute coronary syndrome
下载PDF
导出
摘要 目的探讨超声检查肱动脉血流介导性舒张(FMD)和血清可溶性细胞分化抗原40配体(sCD40L)对急性冠状动脉综合征(ACS)的预测价值。方法随机入选39名健康志愿者、39例稳定性心绞痛患者(SA组)和79例急性冠状动脉综合征(ACS)患者。ACS患者包括不稳定性心绞痛患者49例(UA组),急性心肌梗死患者30例(AMI组)。用超声检查肱动脉FMD,并用ELISA法检测血清sCD40L的含量。研究ACS患者肱动脉FMD和血清sCD40L的变化。用Pearson相关性分析ACS患者肱动脉FMD与血清sCD40L水平的关系。结果肱动脉FMD正常对照组(9.52±2.54)%,SA组(5.35±1.24)%,UA组(3.32±1.41)%,AMI组(3.26±1.32)%,ACS患者肱动脉FMD下调(P<0.05)。血清sCD40L正常对照组(1.21±0.31)ng/ml,SA组(4.12±0.98)ng/ml,UA组(12.86±2.67)ng/ml,AMI组(13.95±2.83)ng/ml,ACS患者血清sCD40L升高(P<0.05)。ACS患者肱动脉FMD与血清sCD40L水平呈负相关,r=-0.708,P=0.000。结论超声发现肱动脉FMD下调,血清sCD40L升高,对ACS有预测价值。 Objective To investigate the predictive value of ACS by brachial artery FMD and sCD 40L. Methods Thirty-nine healthy volunteers(control group), 39 patients with stable angina pectoris(SA group) and 79 patients with acute coronary syndrome (ACS),including 49 patients with unstable angina pectoris (UA group) and 30 patients with acute myocardial infarction (AMI group), were radomly selected.The patients with ACS were detected the brachial artery FMD by ultrasonic testing and the serum sCD 40L by ELISA.Relation of brachial artery FMD and serum sCD40L of ACS patients were analyzed by using Pearson correlation analysis .Results Compared with control group and SA goup , the brachial artery FMD decreased in UA group and AMI group ( 9.52 ±2.54 )%( control group) vs (5.35 ±1.24)%(SA group) vs (3.32 ±1.41)% (UA group) vs (3.26 ±1.32)%(AMI group), (P〈0.05).Compared with control group and SA goup , the serum sCD40L increased in UA group and AMI group (1.21 ± 0.31)ng/ml(control group) vs (4.12 ±0.98)ng/ml(SA group) vs (12.86 ±2.67)ng/ml (UA group) vs (13.95 ± 2.83)ng/ml(AMI group), (P〈0.05).Pearson correlation analysis indicted that the brachial artery FMD was nega-tively associated with the level of serum sCD40L in ACS patients (r=-0.708,P=0.000).Conclusion The down-regulation of brachial artery FMD by ultrasound findings and upregulation of serum sCD 40L have predictive value for the occurrence of ACS .
出处 《中国临床新医学》 2014年第9期803-805,共3页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 佛山市科技攻关项目(编号:200808158)
关键词 肱动脉 血流介导性舒张 可溶性细胞分化抗原40配体 急性冠状动脉综合征 Braehial artery Flow mediated dilatation soluble CD40 ligand (sCD40L) Acute coronary syndrome (ACS)
  • 相关文献

参考文献6

  • 1潘伟,江春苗,刘世明.可溶性CD40配体与心血管事件[J].国际心血管病杂志,2010,37(6):349-352. 被引量:2
  • 2Careri G, Nerla R, Di Monaco A,et al. Clinical correlates and prog- nostic value of flow mediated dilation in patients with non-ST segment elevation acute coronary syndromes [ J]. Am J Cardiol, 2013, 111 (1):51-57.
  • 3娄唯鸣,谭毅.他汀类药物在急性冠状动脉综合征中抗炎作用的研究进展[J].中国临床新医学,2013,6(4):380-384. 被引量:8
  • 4Unek IT, Bayraktar F, Solmaz D, et al. Enhanced levels of soluble CD40 ligand anti C-reactive protein in a total of 312 patients with met- abolic syndrome[J]. Metabolism.2010, 59(3) :305 -313.
  • 5Hamdan R, Hajj F, Kadry Z, et al. Benefit and toleralfility of the co- administration of ezetimibe and atorvastatin in acute coronary syn- drome patients [ J ]. J Med Libau,2011,59 (2) :65 - 69.
  • 6Setianto BY, Hartopo AB, Achadiono DN, et al. Association be- tween levels of circulating soluble CD40 ligand on admission and in- hospital events among acute coronary syndrome patients [ J]. Acta Med Indones, 2011,43 (2) :82 - 87.

二级参考文献68

  • 1刘继东,崔连群,刘尊齐,王晓军,李锋,盖玉生,郭拥军,孔庆赞,赵传艳.阿托伐他汀快速降低老年不稳定性心绞痛患者血清炎症因子浓度[J].中华心血管病杂志,2006,34(10):942-942. 被引量:8
  • 2潘伟,方长庚,刘志平,杨瑞丰,光雪峰.阻塞性睡眠呼吸暂停综合征与急性冠状动脉综合征及冠状动脉病变关系的初步探讨[J].中国介入心脏病学杂志,2007,15(1):25-25. 被引量:3
  • 3朱贵月,朱兴雷,李仁祧,刘同宝,商德亚,张运.单核细胞株THP-1分化为泡沫细胞过程中清道夫受体A变化及阿托伐他汀的干预作用[J].中华心血管病杂志,2007,35(7):666-669. 被引量:6
  • 4Davi G,Tuttolomondo A,Santilli F,et al.CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke[J].J Atheroscler Thromb,2009,16(6):707-713.
  • 5Dominguez-Rodriguez A,Abreu-Gonzalez P,Garcia-Gonzalez MJ,et al.Soluble CD40 ligand:interleukin-10 ratio predicts in-hospital adverse events in patients with ST-segment elevation myocardial infarction[J].Thromb Res,2007,121(3):293-299.
  • 6Antoniades C,Bakogiannis C,Tousoulis D,et al.The CD40/CD40 ligand system:linking inflammation with atherothrombosis[J].J Am Coll Cardiol,2009,54 (8):669-677.
  • 7Unek IT,Bayraktar F,Solmaz D,et al.Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome[J].Metabolism,2010,59(3):305-313.
  • 8Reinboldt S,Wenzel F,Rauch BH,et al.Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets[J].Platelets,2009,20(6):441-444.
  • 9Enomoto Y,Adachi S,Matsushima-Nishiwaki R,et al.Thromboxane A (2) promotes soluble CD40 ligand release from human platelets[J].Atherosclerosis,2010,209 (2):415-421.
  • 10Cholette JM,Blumberg N,Phipps RP,et al.Developmental changes in soluble CD40 ligaod[J].J Pediatr,2008,152(1):50-54.

共引文献8

同被引文献29

引证文献3

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部